175 related articles for article (PubMed ID: 31588660)
41. MRI-Based Surrogate Imaging Markers of Aggressiveness in Prostate Cancer: Development of a Machine Learning Model Based on Radiomic Features.
Dominguez I; Rios-Ibacache O; Caprile P; Gonzalez J; San Francisco IF; Besa C
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685317
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of
Nuo Y; Li A; Yang L; Xue H; Wang F; Wang L
Quant Imaging Med Surg; 2022 Jan; 12(1):53-65. PubMed ID: 34993060
[TBL] [Abstract][Full Text] [Related]
43. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
[TBL] [Abstract][Full Text] [Related]
44. Editorial for "Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques".
Moses DA
J Magn Reson Imaging; 2020 May; 51(5):1554-1555. PubMed ID: 32190936
[TBL] [Abstract][Full Text] [Related]
45. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH; Moon MH
AJR Am J Roentgenol; 2018 Nov; 211(5):W226-W241. PubMed ID: 30240296
[TBL] [Abstract][Full Text] [Related]
46. Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
Eur J Radiol; 2020 Nov; 132():109350. PubMed ID: 33080549
[TBL] [Abstract][Full Text] [Related]
47. Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers.
Cipollari S; Pecoraro M; Forookhi A; Laschena L; Bicchetti M; Messina E; Lucciola S; Catalano C; Panebianco V
Radiol Med; 2022 Nov; 127(11):1245-1253. PubMed ID: 36114928
[TBL] [Abstract][Full Text] [Related]
48. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
49. A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-naïve patients.
Hu B; Zhang H; Zhang Y; Jin Y
Cancer Imaging; 2023 Sep; 23(1):82. PubMed ID: 37667393
[TBL] [Abstract][Full Text] [Related]
50. External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy.
Ninivaggi A; Guzzi F; Degennaro A; Ricapito A; Bettocchi C; Busetto GM; Sanguedolce F; Milillo P; Selvaggio O; Cormio L; Carrieri G; Falagario UG
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685815
[No Abstract] [Full Text] [Related]
51. Usefulness of Bi-Parametric Magnetic Resonance Imaging with b=1,800 s/mm² Diffusion-Weighted Imaging for Diagnosing Clinically Significant Prostate Cancer.
Lee SS; Lee DH; Song WH; Nam JK; Han JY; Lee HJ; Kim TU; Park SW
World J Mens Health; 2020 Jul; 38(3):370-376. PubMed ID: 31385479
[TBL] [Abstract][Full Text] [Related]
52. Development and validation of a nomogram for predicting prostate cancer based on combining contrast-enhanced transrectal ultrasound and biparametric MRI imaging.
Nong W; Huang Q; Gao Y
Front Oncol; 2023; 13():1275773. PubMed ID: 38044995
[TBL] [Abstract][Full Text] [Related]
53. Prebiopsy biparametric MRI: differences of PI-RADS version 2 in patients with different PSA levels.
Choi MH; Lee YJ; Jung SE; Rha SE; Byun JY
Clin Radiol; 2018 Sep; 73(9):810-817. PubMed ID: 29895386
[TBL] [Abstract][Full Text] [Related]
54. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group.
Cho J; Ahn H; Hwang SI; Lee HJ; Choe G; Byun SS; Hong SK
Prostate Int; 2020 Dec; 8(4):146-151. PubMed ID: 33425791
[TBL] [Abstract][Full Text] [Related]
55. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
[TBL] [Abstract][Full Text] [Related]
56. Biparametric
Scialpi M; Prosperi E; D'Andrea A; Martorana E; Malaspina C; Palumbo B; Orlandi A; Falcone G; Milizia M; Mearini L; Aisa MC; Scialpi P; DE Dominicis C; Bianchi G; Sidoni A
Anticancer Res; 2017 Mar; 37(3):1263-1271. PubMed ID: 28314291
[TBL] [Abstract][Full Text] [Related]
57. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
58. A Predictive Model Based on Bi-parametric Magnetic Resonance Imaging and Clinical Parameters for Clinically Significant Prostate Cancer in the Korean Population.
Noh TI; Hyun CW; Kang HE; Jin HJ; Tae JH; Shim JS; Kang SG; Sung DJ; Cheon J; Lee JG; Kang SH
Cancer Res Treat; 2021 Oct; 53(4):1148-1155. PubMed ID: 33421975
[TBL] [Abstract][Full Text] [Related]
59. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
Dwivedi DK; Kumar R; Dwivedi AK; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226
[TBL] [Abstract][Full Text] [Related]
60. Clinically Significant Prostate Cancer Detection With Biparametric MRI: A Systematic Review and Meta-Analysis.
Cuocolo R; Verde F; Ponsiglione A; Romeo V; Petretta M; Imbriaco M; Stanzione A
AJR Am J Roentgenol; 2021 Mar; 216(3):608-621. PubMed ID: 33502226
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
